Genome News and Research

RSS

QTQTN motif upstream of furin-cleavage site in SARS-CoV-2 infection and pathogenesis

A new study posted to the bioRxiv* preprint server aimed to demonstrate whether the loss of the QTQTN motif attenuates SARS-CoV-2 replication in respiratory cells in vitro and pathogenesis in hamsters.

20 Dec 2021

Researchers use machine learning to shed light on genetic mutations linked with spina bifida

Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.

20 Dec 2021

White-tailed deer are efficient carriers of SARS-CoV-2

Researchers demonstrate the susceptibility of white-tailed deer to SARS-CoV-2.

20 Dec 2021

Genomic study of furin cleavage sites validates the natural evolutionary origin of SARS-CoV-2 in bats

A team of researchers describes the genomic region encompassing the furin cleavage site in SARS-CoV-2.

20 Dec 2021

Genome-wide ancient human DNA data from Sudan reveals new insights into the Nile Valley past

The first genome-wide ancient human DNA data from Sudan reveals new insights into the ancestry and social organization of people who lived more than 1,000 years ago in the Nile Valley, an important genetic and cultural crossroads.

20 Dec 2021

Researchers receive CZI grant to support Asian Immune Diversity Atlas project

A team of researchers, led by the Agency for Science, Technology and Research's Genome Institute of Singapore (GIS), was awarded the prestigious Chan Zuckerberg Initiative Ancestry Network Grant in support of their Asian Immune Diversity Atlas (AIDA) project.

18 Dec 2021

A Day in the Life of A Clinical Geneticist

In this interview, we spoke to Dr. Julian Barwell, a clinical geneticist, about his day-to-day roles and responsibilities as well as his career highlights.

17 Dec 2021

Investigating SARS-CoV-2 genomics-informed outbreaks using new bioinformatics tools

Researchers have created a tool designed to make as much use of the overwhelming amount of SARS-CoV-2 data as possible.

17 Dec 2021

Services to accelerate genome editing research

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products.

From AMS Biotechnology 17 Dec 2021

G7 health ministers issue statement on the global threat of Omicron variant

G7 health ministers today held their final meeting of the UK's G7 Presidency, focusing particularly on the very worrying developments on Omicron.

16 Dec 2021

Mutations in histone regulator protein linked to rare neurodevelopmental disorder, cancers

Mutations in a histone regulator protein are linked to both a rare neurodevelopmental disorder and to some cancers, according to a study published in the journal Genes and Development.

16 Dec 2021

Genetic factors partly describe the link between brain structure and chronic pain

Genetic factors partly explain the link between brain structure and chronic pain, according to University of Queensland-led research.

16 Dec 2021

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

A new study highlights the significance of robust T cell responses in preventing severe omicron infections.

16 Dec 2021

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

A new study has used this assay to evaluate sera, obtained from 239 individuals vaccinated via any of the above-stated vaccines against SARS-CoV-2’s original strain, the Delta, and Omicron SARS-CoV-2 pseudoviruses.

16 Dec 2021

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Researchers from Westmead Hospital have been investigating the effect of a third dose on neutralizing antibody titres in already vaccinated individuals.

16 Dec 2021

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

Kaiser Permanente research published on December 15, 2021 in The British Medical Journal showed 2 doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants; however, vaccine effectiveness against the delta variant moderately declined with increasing time after vaccination.

15 Dec 2021

Genome News and Research

QTQTN motif upstream of furin-cleavage site in SARS-CoV-2 infection and pathogenesis

Researchers use machine learning to shed light on genetic mutations linked with spina bifida

White-tailed deer are efficient carriers of SARS-CoV-2

Genomic study of furin cleavage sites validates the natural evolutionary origin of SARS-CoV-2 in bats

Genome-wide ancient human DNA data from Sudan reveals new insights into the Nile Valley past

Researchers receive CZI grant to support Asian Immune Diversity Atlas project

A Day in the Life of A Clinical Geneticist

Investigating SARS-CoV-2 genomics-informed outbreaks using new bioinformatics tools

Services to accelerate genome editing research

G7 health ministers issue statement on the global threat of Omicron variant

Mutations in histone regulator protein linked to rare neurodevelopmental disorder, cancers

Genetic factors partly describe the link between brain structure and chronic pain

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

How SARS-CoV-2 affects the male reproductive system

Signatures of rising SARS-CoV-2 Delta infections in New York

SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment

Researchers spot signs of 'pre-resistance' in bacteria for the first time

The art of CRISPR: The power and promise of gene editing eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News